Keith Meister, Corvex Management’s chief investment officer, will join Illumina’s board starting March 28. He’s no stranger to the world of biotech.

Keith Meister, Corvex Management’s chief investment officer, will join Illumina’s board starting March 28. He’s no stranger to the world of biotech.

Keith Meister, Corvex Management’s chief investment officer, will join Illumina’s board starting March 28. He’s no stranger to the world of biotech.

Corvex Management LP has taken a stake in Fortrea Holdings Inc., a clinical trials management company that was spun out of Labcorp Holdings Inc. Bloomberg Published 23 Oct 2024, 04:05 AM IST ...

The Corvex news comes after fellow prominent activist investor Starboard Value first disclosed a stake in Fortea (FTRE) last October. Starboard had a 8.9% stake in Fortrea as of the end of June ...

Date 10/22/2024 7:00:44 PM (MENAFN - Live Mint) (Bloomberg) -- Corvex Management LP has taken a stake in Fortrea Holdings Inc., a clinical trials management company that was spun out of Labcorp ...

On May 24, Corvex Management purchased 100,000 shares of Vestis Corp at an average price of $12.02 per share, amounting to a total investment of $1.2 million.

Corvex acquired approximately 25% of its position at prices as high as $19.39 per share prior to the stock falling, and the firm accelerated its purchases in the aftermath of the Q2 '24 results.